Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake? Reply to Zhou S, Li D, Zhou Y [letter]

[1]  Da Li,et al.  Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake? , 2015, Diabetologia.

[2]  A. Tönjes,et al.  Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance , 2015, Diabetologia.

[3]  Alexander S. Banks,et al.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity , 2014, Nature.

[4]  S. Schuster,et al.  Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. , 2013, Nature chemical biology.

[5]  Yu Cao,et al.  Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats , 2013, British Journal of Nutrition.

[6]  B. Cravatt,et al.  NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink , 2013, Nature chemical biology.

[7]  Wuping Sun,et al.  B-vitamin consumption and the prevalence of diabetes and obesity among the US adults: population based ecological study , 2010, BMC public health.

[8]  Chang-Bin Sun,et al.  Nicotinamide overload may play a role in the development of type 2 diabetes. , 2009, World journal of gastroenterology.

[9]  R. Zechner,et al.  Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. , 2009, Atherosclerosis.

[10]  R. Cox,et al.  A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.

[11]  A. Chang,et al.  Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance , 2006 .

[12]  S. Kahn,et al.  Nicotinamide's Effects on Glucose Metabolism in Subjects at Risk For IDDM , 1996, Diabetes.

[13]  N. Pla.  Chronic niacin overload may be involved in the increased prevalence of obesity in US children , 2010 .

[14]  A. Chang,et al.  Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  R. Bergman,et al.  Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. , 1989, Diabetes.